Q4 2023 update: M&A activity in pharmaceutical in Italy
In the Italian pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $6.9bn,…
All articles by Staff Writer
Staff Writer
-
-
Q4 2023 update: M&A activity in pharmaceutical in Middle East and Africa
In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total…
-
Q4 2023 update: private equity deals in pharmaceutical in India
In the Indian pharmaceutical industry, there were 3 private equity deals announced in Q4 2023, worth a total value of…
-
How did Private equity deals perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 66 private equity deals announced in Q4 2023, worth a total value of…
-
Q4 2023 update: M&A activity in pharmaceutical in Australia
In the Australian pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $276.3m,…
-
Q4 2023 update: M&A activity in pharmaceutical in Germany
In the German pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $45m,…
-
Q4 2023 update: M&A activity in pharmaceutical in South and Central America
In the South and Central America pharmaceutical industry, there were 5 M&A deals announced in Q4 2023, worth a total…
-
Q4 2023 update: M&A activity in pharmaceutical in China
In the Chinese pharmaceutical industry, there were 29 M&A deals announced in Q4 2023, worth a total value of $3.5bn,…
-
Q4 2023 update: M&A activity in pharmaceutical in Brazil
In the Brazilian pharmaceutical industry, there were 3 M&A deals announced in Q4 2023, worth a total value of $4.2m,…
-
Q4 2023 update: private equity deals in pharmaceutical in China
In the Chinese pharmaceutical industry, there were 2 private equity deals announced in Q4 2023, worth a total value of…